The latest company updates, technical articles, and industry content.
HAp drug-carrier research for localized bone-tumor applications is gaining attention. A recent RSC Advances study provides context for dispersion behavior, formulation sensitivity, in vitro evidence limits, and batch data.
View Details
The Beijing-Tianjin-Hebei warning brings the discussion back to CaHA particle morphology, particle-size distribution, sterile processing, and compliant product scope.
View Details
β-TCP degradation pace in bone repair materials is shaped by sintering, residual α-TCP, Ca/P ratio, surface area, and particle grading at the raw-material level.
View Details
As downstream teams seek more reproducible tissue-response research, injectability evaluation, and product verification, CaHA powder quality is becoming a core variable.
View Details
HAp-related microspheres are being studied as material platforms for osteoporotic bone defect repair, where osteoimmune modulation and microenvironment remodeling are increasingly important.
View Details
Solid hydroxyapatite microspheres are relevant to aesthetic regenerative materials because dense spherical particles can support stable formulation design and long-term structural function.
View Details